Genetic test identifies if your eye cancer will spread

Cancer tumor test says it can identify, with 97% accuracy, whether your ocular melanoma will spread to other parts of your body.

“When the cancer spreads beyond the eye, it’s unlikely any therapy is going to be effective,” says principal investigator J. William Harbour, MD. “But it’s very possible that we can develop treatments to slow the growth of metastatic tumors. The real importance of this test is that by identifying the type of tumor a patient has, we can first remove the tumor from the eye with surgery or radiation and then get those individuals at high risk into clinical trials that might be able to help them live longer.”

Read more…

Life Is Change: OM is an Opportunity

As I struggle to find something to write about, on this blog, about my life and the disease, the cancer I carry, it’s hard to pout the emotions into words.

I do have, though, the things I never thought I’d be saying a year ago (bear with me, this is my idea of humor):

– My eye feels upside down
– Should I wear my “Happy Face” today?
– I know why I didn’t see that coming!
– You look great in 2D
– Yes, you only need one eye to drive
– Don’t you love how real my new eye looks?

I could go on but that would be giving away most of my game…lol.

Life gives you what it will and you’re responsible how you handle it. Take it from me, it’ better to do it with a smile than a snarl.

Blog crashed for a few days

Hi All,

For some reason my blog database crashed but I have now fully restored the blog.

Thank you for your patience.

Robert Lee

Novel Technique Shows Promise for Ocular Melanoma

Percutaneous hepatic perfusion could be useful for colon, neuroendocrine cancers

Stockholm — Mature data from an ongoing trial of percutaneous hepatic perfusion (PHP)— a novel technique in which chemotherapy is infused directly into the liver—continue to show improved progression-free survival (PFS) for patients with liver metastases from ocular melanoma.

Researchers say the PHP technique could be used to treat other tumors that cause liver metastases, such as neuroendocrine or colon, if trials yield positive results. This news comes from a study reported by investigators from the University of Pittsburgh at the 2011 European Multidisciplinary Cancer Congress (EMCC).

“This is the first treatment to show a clinical benefit in patients with liver metastases from ocular melanoma,” said lead investigator James Pingpank, MD, professor of surgery at the University of Pittsburgh School of Medicine and a surgical oncologist with UPMC Cancer Centers.

Read the complete article here